MDXG vs MET · P/E 18, rev $123.4M vs P/E 13, rev $38.23B
MiMedx Group Inc (MDXG) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported MDXG revenue for 2026-06-30 was $123.4M. Net income was -$25.7M. MDXG currently screens at market cap $537.7M and trailing P/E 18.1.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
MDXG currently screens at market cap $537.7M and trailing P/E 18.1. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the MDXG and MET stock pages for the full models.
Not investment advice.